Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 3/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.42 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.42 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.39 |
| ▸ | DNMT3B | Q9UBC3 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.34 |
| ▸ | PDE2A | O00408 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.34 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.34 |
| ▸ | CD99 | P14209 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.33 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.33 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.33 |
| ▸ | GAPDH | P04406 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18947560 | 0.86 | AHCY (0.44) | AHCYADORA2AADORA2BDNMT1DNMT3B | |
| SCHEMBL24831397 | 0.86 | AHCY (0.55) | AHCYADORA2AADORA2BALDH1A1HIF1A | |
| SCHEMBL17927851 | 0.86 | AHCY (0.55) | AHCYADORA2AADORA2BALDH1A1HIF1A | |
| SCHEMBL16214136 | 0.86 | AHCY (0.55) | AHCYADORA2AADORA2BALDH1A1HIF1A | |
| SCHEMBL16367937 | 0.82 | AHCY (0.41) | AHCYADORA2AADORA2BDNMT1DNMT3B | |
| SCHEMBL21614180 | 0.82 | NT5E (0.52) | AHCYADORA2AADORA2BDNMT1DNMT3B | |
| SCHEMBL16214074 | 0.82 | AHCY (0.41) | AHCYADORA2AADORA2BALDH1A1HIF1A | |
| SCHEMBL26311389 | 0.82 | ADORA2A (0.42) | AHCYADORA2AADORA2BDNMT1DNMT3B | |
| SCHEMBL18072191 | 0.80 | ADORA3 (0.48) | ADORA3PDE3A | |
| SCHEMBL16214090 | 0.80 | ADORA3 (0.48) | ADORA3PDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230277576-A1 | A METHOD FOR PREVENTING OR TREATING A CORNAVIRUS INFECTIOUS DISEASE | HENAN GENUINE BIOTECH CO., LTD. (CN) | 2023-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230277576-A1 | A METHOD FOR PREVENTING OR TREATING A CORNAVIRUS INFECTIOUS DISEASE | ACE, ACE2, SARS1 | AHCY 1014/4885ADORA2A 4232/4885ADORA2B 3951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.